Mr. Rowland has been a member of the board since March. He will replace the company’s founder and current CEO Elazar Sonnenschein, MD, upon shareholder approval.
Mr. Rowland served for 17 years as a manager for Boston Scientific and has 24 years of experience in the life sciences market.
Medigus develops minimally invasive endoscopic techniques for gastroesophageal reflux disease treatment.
More Articles on Gastroenterology:
GI, Endoscopy Video Journal Released by Elsevier
Study: Probiotics May Not Relieve Antibiotic-Associated Diarrhea in Elderly
European Researchers Zero In On Possible Bowel Disease Cause
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.